U.S. Stock Market Summary – May 6, 2025: S&P 500 Falls Again as Palantir, Drugmakers Slide

  • Weekly Giveaway for our active users. N50,000 per Week. Do you want to contribute to this community? We are looking for contribution? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing Nigerian forum!
S

Samiat

Member
Nov 12, 2024
402
4
18

U.S. Stock Market Summary – May 6, 2025: S&P 500 Falls Again as Palantir, Drugmakers Slide​

Meta Description (SEO-friendly):
U.S. stocks fell for the second day on May 6, 2025, with the S&P 500 down 0.8% as Palantir and pharmaceutical stocks declined. Investors await Fed rate decision and tariff updates.

Key Takeaways​

  • The S&P 500 fell 0.8% on Tuesday, marking a second straight day of losses as markets awaited the Federal Reserve’s interest rate announcement and clarity on U.S. trade tariffs.
  • Palantir Technologies plunged 12% after mixed earnings and valuation concerns.
  • Vertex Pharmaceuticals and Moderna tumbled following the pause of a cystic fibrosis trial.
  • Constellation Energy soared 10% on strong earnings tied to rising AI-driven electricity demand.

Market Performance – May 6, 2025​

U.S. equities declined again on Tuesday as traders digested corporate earnings, geopolitical trade updates, and anticipated tomorrow’s Federal Reserve policy meeting. The S&P 500 dropped 0.8%, while the Dow Jones Industrial Averagefell 1% and the Nasdaq Composite declined 0.9%.

This marks the second consecutive day of declines following a nine-day winning streak.

Notable Stock Movers​

Palantir Technologies (PLTR) dropped 12% after reporting earnings that met expectations, but failed to impress investors. Despite a 39% surge in quarterly revenue and a raised 2025 outlook, concerns over Palantir’s lofty valuation—up 400% year-over-year—led to the pullback.

Vertex Pharmaceuticals (VRTX) plunged 10%, while Moderna (MRNA) also fell after the two companies paused a cystic fibrosis clinical trial, contributing to a disappointing earnings report for Vertex.

DoorDash (DASH) fell over 7% after releasing earnings early and announcing acquisitions of Deliveroo for nearly $4 billion and SevenRooms for $1.2 billion. Revenue came in below expectations.

On the upside, Constellation Energy (CEG) led the S&P 500 with a 10% gain. The utility firm benefited from booming AI-related electricity consumption, beat revenue estimates, and reaffirmed its 2025 guidance. The company also confirmed its $26.6 billion acquisition of Calpine is on track for year-end completion.

Leidos Holdings (LDOS) gained 4.6% after posting stronger-than-expected results and downplaying potential fallout from reduced U.S. government spending.

Ford Motor (F) rose 2.7% on solid earnings, although it suspended full-year guidance due to tariff uncertainty.

Super Micro Computer (SMCI) gained 2.4% ahead of its earnings report due after the closing bell.

Other Movers​

  • Marriott International rose 1.9% on strong Q1 results, despite lowering its full-year room revenue guidance.
  • TreeHouse Foods declined 5.8% after issuing weak forward sales guidance and citing consumption slowdowns and product recalls.

Bonds, Commodities, and Treasury Yields​

  • 10-Year Treasury Yield: Fell 3.7 basis points to 4.31%
  • 2-Year Treasury Yield: Dropped 4.2 basis points to 3.8%
Crude Oil (WTI) climbed 3.4% to $59.09 per barrel, boosted by global supply concerns.

Gold surged 3.2% to $3,428.90 per ounce, and Silver rose 2.9% to $33.42 per ounce, reflecting growing investor demand for safe-haven assets.
 
You must log in or register to reply here.
Top Bottom